Johnson & Johnson
JNJ
154.615
USD-0.77
(-0.49%)Day's range
153.63
155.895
52 wk Range
140.68
169.99
Key ratios
Statements Highlights
| Period Ending | Jan 03, 2021 | Jan 02, 2022 | Jan 01, 2023 | Dec 31, 2023 | Dec 29, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 82,584,000,000 | 78,740,000,000 | 79,990,000,000 | 85,159,000,000 | 88,821,000,000 | |
| Gross Profit | 54,157,000,000 | 55,338,000,000 | 55,394,000,000 | 58,606,000,000 | 61,350,000,000 | |
| Operating Income | 19,733,000,000 | 20,943,000,000 | 21,013,000,000 | 23,409,000,000 | 22,149,000,000 | |
| Net Income | 14,714,000,000 | 20,878,000,000 | 17,941,000,000 | 35,153,000,000 | 14,066,000,000 | |
| Total Assets | 174,894,000,000 | 182,018,000,000 | 187,378,000,000 | 167,558,000,000 | 180,104,000,000 | |
| Total Current Liabilities | 42,493,000,000 | 45,226,000,000 | 55,802,000,000 | 46,282,000,000 | 50,321,000,000 | |
| Total Equity | 63,278,000,000 | 74,023,000,000 | 76,804,000,000 | 68,774,000,000 | 71,490,000,000 | |
| Free Cash Flow | 20,189,000,000 | 19,758,000,000 | 17,185,000,000 | 18,248,000,000 | 19,842,000,000 | |
| Cash from Operations | 23,536,000,000 | 23,410,000,000 | 21,194,000,000 | 22,791,000,000 | 24,266,000,000 | |
| Cash from Investing | -20,825,000,000 | -8,683,000,000 | -12,371,000,000 | 878,000,000 | -18,599,000,000 | |
| Cash from Financing | -6,120,000,000 | -14,047,000,000 | -8,871,000,000 | -15,825,000,000 | -3,132,000,000 | |
| Net Change in Cash | -3,320,000,000 | 502,000,000 | -360,000,000 | 7,732,000,000 | 2,246,000,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy